| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Clinical Studies |
Departments of Endocrinology (J.N.-P., J.M., M.S., M.B., A.G.) and Chemical Endocrinology (L.P., S.M.), St. Bartholomews Hospital, West Smithfield, London, United Kingdom EC1A 7BE
Address all correspondence and requests for reprints to: Dr. Ashley Grossman, Department of Endocrinology, St. Bartholomews Hospital, West Smithfield, London, United Kingdom EC1A 7BE. E-mail: a.b.grossman{at}mds.qmw.ac.uk
To assess the ability of desmopressin to differentiate between pituitary and ectopic ACTH-dependent Cushings syndrome and to determine whether diagnostic accuracy could be improved by administering it together with human sequence CRH, we examined its effects on cortisol and ACTH secretion when given alone or in combination with CRH in patients with Cushings syndrome of varied etiology and compared these data to the results of a standard CRH test in the same individuals.
Each patient was studied on three occasions, in random order, separated by at least 48 h. At 0900 h, via an indwelling forearm cannula, 10 µg desmopressin, 100 µg CRH, or a combination of the two were given as an iv bolus; thereafter, blood was drawn every 15 min for 2 h. The responses to the individual agents were determined according to the timing and calculation criteria suggested by Nieman et al. (1993). A total of 25 patients with Cushings syndrome were studied: 17 patients with pituitary-dependent Cushings syndrome, Cushings disease (CD); 5 patients with occult ectopic ACTH secretion (EC); and 3 patients with primary adrenal (ACTH-independent) Cushings syndrome.
In this series, the best discrimination among ACTH-dependent patient groups was achieved using the combined test. Using the responses of plasma cortisol, all 17 patients with CD showed a rise greater than any of the 5 patients with EC, whereas 1 patient with CD showed a plasma ACTH response within the range seen in the patients with EC. Plasma cortisol responses to desmopressin alone were seen in 14 of 17 patients with CD and 1 of 5 patients with EC and, after CRH alone, in 15 of 17 patients with CD but in no patient with EC. In contrast, plasma ACTH responses after CRH alone were seen in 14 of 17 patients with CD and 2 of 5 patients with EC and, after desmopressin alone, in 12 of 17 with CD and 3 of 5 with EC, thus indicating overlapping responses between the groups and poorer discrimination. No responses were seen in the ACTH-independent group.
These data indicate that desmopressin causes the secretion of ACTH and cortisol in patients with ACTH-dependent Cushings syndrome, and that in combination with CRH, it may provide an improvement over the standard CRH test in the differential diagnosis of ACTH-dependent Cushings syndrome. Furthermore, these data suggest that there may be abnormalities in vasopressin receptor function or number in ACTH-secreting tumors.
This article has been cited by other articles:
![]() |
S. Tsagarakis, D. Vassiliadi, I. S. Kaskarelis, J. Komninos, E. Souvatzoglou, and N. Thalassinos The Application of the Combined Corticotropin-Releasing Hormone plus Desmopressin Stimulation during Petrosal Sinus Sampling Is Both Sensitive and Specific in Differentiating Patients with Cushing's Disease from Patients with the Occult Ectopic Adrenocorticotropin Syndrome J. Clin. Endocrinol. Metab., June 1, 2007; 92(6): 2080 - 2086. [Abstract] [Full Text] [PDF] |
||||
![]() |
R M Testa, N Albiger, G Occhi, F Sanguin, M Scanarini, S Berlucchi, M P Gardiman, C Carollo, F Mantero, and C Scaroni The usefulness of combined biochemical tests in the diagnosis of Cushing's disease with negative pituitary magnetic resonance imaging Eur. J. Endocrinol., February 1, 2007; 156(2): 241 - 248. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Isidori, G. A. Kaltsas, C. Pozza, V. Frajese, J. Newell-Price, R. H. Reznek, P. J. Jenkins, J. P. Monson, A. B. Grossman, and G. M. Besser The Ectopic Adrenocorticotropin Syndrome: Clinical Features, Diagnosis, Management, and Long-Term Follow-Up J. Clin. Endocrinol. Metab., February 1, 2006; 91(2): 371 - 377. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Isidori, G. A. Kaltsas, S. Mohammed, D. G. Morris, P. Jenkins, S. L. Chew, J. P. Monson, G. M. Besser, and A. B. Grossman Discriminatory Value of the Low-Dose Dexamethasone Suppression Test in Establishing the Diagnosis and Differential Diagnosis of Cushing's Syndrome J. Clin. Endocrinol. Metab., November 1, 2003; 88(11): 5299 - 5306. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Terzolo, G. Reimondo, and A. Angeli Desmopressin Test in Mild Cushing Syndrome Arch Intern Med, April 14, 2003; 163(7): 850 - 851. [Full Text] [PDF] |
||||
![]() |
P. Chiodera, R. Volpi, M. Bianconcini, M. L. Bortesi, G. Manfredi, and V. Coiro Desmopressin Test in Occult Eutopic Corticotropin Microadenoma Arch Intern Med, April 8, 2002; 162(7): 840 - 841. [Full Text] [PDF] |
||||
![]() |
J. Newell-Price, D. G. Morris, W. M. Drake, M. Korbonits, J. P. Monson, G. M. Besser, and A. B. Grossman Optimal Response Criteria for the Human CRH Test in the Differential Diagnosis of ACTH-Dependent Cushing's Syndrome J. Clin. Endocrinol. Metab., April 1, 2002; 87(4): 1640 - 1645. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Tsagarakis, C. Tsigos, V. Vasiliou, P. Tsiotra, J. Kaskarelis, C. Sotiropoulou, S. A. Raptis, and N. Thalassinos The Desmopressin and Combined CRH-Desmopressin Tests in the Differential Diagnosis of ACTH-Dependent Cushing's Syndrome: Constraints Imposed by the Expression of V2 Vasopressin Receptors in Tumors with Ectopic ACTH Secretion J. Clin. Endocrinol. Metab., April 1, 2002; 87(4): 1646 - 1653. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Dall'Asta, L. Santambrogio, M. Castellani, and B. Ambrosi Difficulties in diagnosis and treatment of ectopic ACTH-producing tumors of the chest Eur. J. Cardiothorac. Surg., January 1, 2002; 21(1): 149 - 151. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Moro, P. Putignano, M. Losa, C. Invitti, C. Maraschini, and F. Cavagnini The Desmopressin Test in the Differential Diagnosis between Cushing's Disease and Pseudo-Cushing States J. Clin. Endocrinol. Metab., October 1, 2000; 85(10): 3569 - 3574. [Abstract] [Full Text] |
||||
![]() |
M. Korbonits, G. Kaltsas, L. A. Perry, P. Putignano, A. B. Grossman, G. M. Besser, and P. J. Trainer The Growth Hormone Secretagogue Hexarelin Stimulates the Hypothalamo-Pituitary-Adrenal Axis via Arginine Vasopressin J. Clin. Endocrinol. Metab., July 1, 1999; 84(7): 2489 - 2495. [Abstract] [Full Text] |
||||
![]() |
P. L. M. Dahia and A. B. Grossman The Molecular Pathogenesis of Corticotroph Tumors Endocr. Rev., April 1, 1999; 20(2): 136 - 155. [Abstract] [Full Text] |
||||
![]() |
G. A. Kaltsas, M. G. Giannulis, J. D. C. Newell-Price, J. E. Dacie, C. Thakkar, F. Afshar, J. P. Monson, A. B. Grossman, G. M. Besser, and P. J. Trainer A Critical Analysis of the Value of Simultaneous Inferior Petrosal Sinus Sampling in Cushing's Disease and the Occult Ectopic Adrenocorticotropin Syndrome J. Clin. Endocrinol. Metab., February 1, 1999; 84(2): 487 - 492. [Abstract] [Full Text] |
||||
![]() |
J. Newell-Price, P. Trainer, M. Besser, and A. Grossman The Diagnosis and Differential Diagnosis of Cushing's Syndrome and Pseudo-Cushing's States Endocr. Rev., October 1, 1998; 19(5): 647 - 672. [Abstract] [Full Text] |
||||
![]() |
W. M. Drake, L. A. Perry, C. J. Hinds, D. G. Lowe, R. H. Reznek, and G. M. Besser Emergency and Prolonged Use of Intravenous Etomidate to Control Hypercortisolemia in a Patient with Cushing's Syndrome and Peritonitis J. Clin. Endocrinol. Metab., October 1, 1998; 83(10): 3542 - 3544. [Abstract] [Full Text] |
||||
![]() |
G. L. Booth, D. A. Redelmeier, H. Grosman, K. Kovacs, H. S. Smyth, and S. Ezzat Improved Diagnostic Accuracy of Inferior Petrosal Sinus Sampling over Imaging for Localizing Pituitary Pathology in Patients with Cushing's Disease J. Clin. Endocrinol. Metab., July 1, 1998; 83(7): 2291 - 2295. [Abstract] [Full Text] |
||||
![]() |
P. L. M. Dahia, J. Honegger, M. Reincke, R. A. Jacobs, A. Mirtella, R. Fahlbusch, G. M. Besser, S. L. Chew, and A. B. Grossman Expression of Glucocorticoid Receptor Gene Isoforms in Corticotropin-Secreting Tumors J. Clin. Endocrinol. Metab., April 1, 1997; 82(4): 1088 - 1093. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |